{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:39Z","timestamp":1786119519478,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/hpc.0b013e318200ec27","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T07:58:12Z","timestamp":1291103892000},"page":"227-230","source":"Crossref","is-referenced-by-count":12,"title":["Receptor Activator of Nuclear Factor Kappa B Ligand\/Osteoprotegerin Pathway Is a Promising Target to Reduce Atherosclerotic Plaque Calcification"],"prefix":"10.1097","volume":"9","author":[{"given":"Alessandra","family":"Quercioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Luciano Viviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Dallegri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210126","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM199711063371906","article-title":"Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.","volume":"337","author":"Braunwald","year":"1997","journal-title":"N Engl J Med"},{"key":"R2-9-20210126","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCULATIONAHA.104.488916","article-title":"Coronary calcification improves cardiovascular risk prediction in the elderly.","volume":"112","author":"Vliegenthart","year":"2005","journal-title":"Circulation"},{"key":"R3-9-20210126","doi-asserted-by":"crossref","first-page":"75805","DOI":"10.1155\/2007\/75805","article-title":"The immune response is involved in atherosclerotic plaque calcification: could the RANKL\/RANK\/OPG system be a marker of plaque instability?","volume":"2007","author":"Montecucco","year":"2007","journal-title":"Clin Dev Immunol"},{"key":"R4-9-20210126","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque.","volume":"47","author":"Virmani","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R5-9-20210126","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2006.02.005","article-title":"Coronary artery calcium score, risk factors, and incident coronary heart disease events.","volume":"190","author":"Church","year":"2007","journal-title":"Atherosclerosis"},{"key":"R6-9-20210126","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcmg.2009.03.009","article-title":"Absence of coronary artery calcification and all-cause mortality.","volume":"2","author":"Blaha","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"R7-9-20210126","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jacc.2006.10.001","article-title":"ACCF\/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF\/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography.","volume":"49","author":"Greenland","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R8-9-20210126","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: pathobiology of a multifaceted disease.","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"key":"R9-9-20210126","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"R10-9-20210126","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","article-title":"RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.","volume":"22","author":"Schoppet","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R11-9-20210126","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases.","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"R12-9-20210126","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/art.20352","article-title":"Expression and function of RANK in human monocyte chemotaxis.","volume":"50","author":"Mosheimer","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R13-9-20210126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1359\/JBMR.051027","article-title":"Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.","volume":"21","author":"Kindle","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R14-9-20210126","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/CIRCRESAHA.108.189001","article-title":"RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.","volume":"104","author":"Panizo","year":"2009","journal-title":"Circ Res"},{"key":"R15-9-20210126","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.ATV.0000204334.48195.6a","article-title":"Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization.","volume":"26","author":"Sandberg","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R16-9-20210126","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/CIRCULATIONAHA.106.686774","article-title":"Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease.","volume":"116","author":"Kiechl","year":"2007","journal-title":"Circulation"},{"key":"R17-9-20210126","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000232941","article-title":"Relationship of sRANKL level and vascular calcification score to cardiovascular events in maintenance hemodialysis patients.","volume":"28","author":"Wei","year":"2009","journal-title":"Blood Purif"},{"key":"R18-9-20210126","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/CIRCULATIONAHA.107.707380","article-title":"Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in LDLR(\u2212\/\u2212) mice.","volume":"117","author":"Morony","year":"2008","journal-title":"Circulation"},{"key":"R19-9-20210126","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1538-7836.2010.03790.x","article-title":"Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population-the Tromso Study.","volume":"8","author":"Vik","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R20-9-20210126","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2010.03.013","article-title":"Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity.","volume":"55","author":"Venuraju","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R21-9-20210126","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"R22-9-20210126","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1291\/hypres.31.1163","article-title":"Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients.","volume":"31","author":"Mikami","year":"2008","journal-title":"Hypertens Res"},{"key":"R23-9-20210126","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1515\/CCLM.2009.075","article-title":"Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease.","volume":"47","author":"Mesquita","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"R24-9-20210126","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2362.2010.02308.x","article-title":"Coronary artery calcification and cardiovascular risk: the role of RANKL\/OPG signalling.","volume":"40","author":"Quercioli","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"R25-9-20210126","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","article-title":"Osteoimmunology and the effects of the immune system on bone.","volume":"5","author":"Takayanagi","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"R26-9-20210126","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/13543780903048929","article-title":"RANKL inhibition for the management of patients with benign metabolic bone disorders.","volume":"18","author":"Anastasilakis","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"R27-9-20210126","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis.","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"R28-9-20210126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/acr.20004","article-title":"Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients.","volume":"62","author":"Deodhar","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R29-9-20210126","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2008.19.2146","article-title":"Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.","volume":"27","author":"Fizazi","year":"2009","journal-title":"J Clin Oncol"},{"key":"R31-9-20210126","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","article-title":"Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial.","volume":"43","author":"Miller","year":"2008","journal-title":"Bone"},{"key":"R32-9-20210126","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/rheumatology\/ken395","article-title":"Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.","volume":"48","author":"Montecucco","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R33-9-20210126","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1055\/s-0029-1224109","article-title":"Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis.","volume":"41","author":"Anastasilakis","year":"2009","journal-title":"Horm Metab Res"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00132577-201012000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:43:39Z","timestamp":1786041819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00132577-201012000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0b013e318200ec27","relation":{},"ISSN":["1535-282X"],"issn-type":[{"value":"1535-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}